Claritas Pharmaceuticals (OTCMKTS:KALTF) Stock Crosses Below 200 Day Moving Average of $0.03

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTFGet Rating) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.03 and traded as low as $0.01. Claritas Pharmaceuticals shares last traded at $0.01, with a volume of 250 shares changing hands.

Claritas Pharmaceuticals Stock Up 999,900.0 %

The company has a 50 day moving average price of $0.02 and a 200-day moving average price of $0.03.

Claritas Pharmaceuticals Company Profile

(Get Rating)

Claritas Pharmaceuticals, Inc engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.

Recommended Stories

Receive News & Ratings for Claritas Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Claritas Pharmaceuticals and related companies with's FREE daily email newsletter.